EyePoint Pharmaceuticals, Inc.
EYPT
$11.21
$0.131.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.63% | -14.21% | 46.15% | -9.44% | -6.38% |
| Total Receivables | 41.40% | -27.18% | 60.58% | -72.51% | -54.39% |
| Inventory | 25.79% | -7.64% | -17.88% | -23.56% | -13.74% |
| Prepaid Expenses | -3.61% | -40.35% | -21.39% | 19.86% | -10.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.21% | -0.28% | 8.24% | 21.88% | -28.19% |
| Total Current Assets | -18.88% | -14.69% | 42.73% | -8.95% | -7.17% |
|
|
|||||
| Total Current Assets | -18.88% | -14.69% | 42.73% | -8.95% | -7.17% |
| Net Property, Plant & Equipment | 1.00% | 1.29% | -2.08% | 2.15% | 156.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.30% | 0.75% | 132.58% | 1,614.67% | 0.00% |
| Total Assets | -16.94% | -13.36% | 39.06% | -7.20% | -1.52% |
|
|
|||||
| Total Accounts Payable | 19.89% | 40.08% | 59.62% | -48.64% | 101.86% |
| Total Accrued Expenses | -37.02% | 0.79% | 29.30% | 9.39% | -16.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.47% | 41.78% | 4.97% | 5.13% | 2.91% |
| Total Finance Division Other Current Liabilities | -96.46% | -70.25% | -31.29% | -22.38% | -13.15% |
| Total Other Current Liabilities | -96.46% | -70.25% | -31.29% | -22.38% | -13.15% |
| Total Current Liabilities | -20.40% | -15.03% | 0.52% | -21.43% | -0.76% |
|
|
|||||
| Total Current Liabilities | -20.40% | -15.03% | 0.52% | -21.43% | -0.76% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.24% | 2.09% | -0.29% | -1.09% | 379.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -16.38% | -98.40% | -3.57% | -1.81% | -3.56% |
| Total Liabilities | -14.07% | -21.71% | -0.27% | -14.34% | 20.97% |
|
|
|||||
| Common Stock & APIC | 0.59% | 0.60% | 15.18% | 1.88% | 0.91% |
| Retained Earnings | -6.47% | -5.18% | -4.98% | -3.66% | -4.00% |
| Treasury Stock & Other | -9.86% | -10.21% | -12.21% | 47.85% | -5.26% |
| Total Common Equity | -17.56% | -11.32% | 53.84% | -4.19% | -8.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.56% | -11.32% | 53.84% | -4.19% | -8.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.56% | -11.32% | 53.84% | -4.19% | -8.65% |
|
|
|||||